Iceland Press Releases

Published on June 11, 2024 - 08:00 GMT

Alvotech and STADA add to strategic alliance through denosumab partnership

STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle East This partnership for the …

Distribution channels: Companies, Technology ...

Published on June 7, 2024 - 08:00 GMT

Alvotech Announces Strategic Refinancing Agreement

REYKJAVIK, Iceland, June 07, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the successful arrangement of a …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on June 4, 2024 - 17:08 GMT

EIN Presswire Underwrites Registration for Students to Attend the Public Relations Student Society of America ICON Event

Applications being accepted until June 21, 2024 WASHINGTON, D.C., UNITED STATES, June 4, 2024 /⁨EINPresswire.com⁩/ -- Newsmatics, a Washington, D.C.-based news tech company, will underwrite the registration of up to 50 college students to attend the …

Distribution channels: Agriculture, Farming & Forestry Industry, Amusement, Gaming & Casino ...

Published on May 29, 2024 - 12:05 GMT

Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024

REYKJAVIK, Iceland, May 29, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies …

Distribution channels:

Published on May 23, 2024 - 16:55 GMT

Kópavogsbær gefur út nýjan skuldabréfaflokk KOP 24 1

Kópavogsbær gefur út nýjan skuldabréfaflokk KOP 24 1 Kópavogsbær lauk í dag útboði á nýjum skuldabréfaflokki KOP 24 1. Um er að ræða verðtryggt skuldabréf sem ber fasta 3,25% vexti og munu höfuðstólsafborganir ásamt vöxtum greiðast með jafngreið …

Distribution channels:

Published on May 21, 2024 - 21:15 GMT

Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update

Total revenues in Q1 2024 increased to $37 million compared to $16 million in the same period last year. Gross margin in Q1 2024 increased to $17 million, by $40 million compared to the same period last year. Alvotech signed new commercialization …

Distribution channels:

Published on May 21, 2024 - 12:00 GMT

Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & ...

Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK) Alvotech will be responsible for development and manufacture of the product HYDERABAD, India and REYKJAVIK, …

Distribution channels: Companies, Technology ...

Published on May 21, 2024 - 00:25 GMT

Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.

SIMLANDI is the first interchangeable high-concentration, citrate-free biosimilar to Humira® REYKJAVIK, Iceland and PARSIPPANY, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and …

Distribution channels:

Published on May 16, 2024 - 14:59 GMT

EIN Presswire Gifts More Than 2,500 Free Press Releases to Small Business Owners

Small businesses discover how press release distribution can boost brand awareness WASHINGTON, DC, USA, May 16, 2024 /⁨EINPresswire.com⁩/ -- Earlier this month, EIN Presswire shared their story with thousands of prospective clients at the Small Business …

Distribution channels: Agriculture, Farming & Forestry Industry, Amusement, Gaming & Casino ...

Published on May 13, 2024 - 12:00 GMT

Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (12 noon GMT)

REYKJAVIK, Iceland, May 13, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for …

Distribution channels:

Published on May 2, 2024 - 11:15 GMT

Alvotech Announces Participation at BofA Securities Healthcare Conference 2024

REYKJAVIK, Iceland, May 02, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of management would be …

Distribution channels:

Published on May 1, 2024 - 11:00 GMT

Zil Simplifies US Payments for Icelandic Entrepreneurs

TYLER, TEXAS, UNITED STATES, May 1, 2024 /⁨EINPresswire.com⁩/ -- Zil US, a leading B2B payment platform, offers a unique opportunity for Icelandic entrepreneurs and freelancers to open US payment accounts from the comfort of their homes. This …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on April 30, 2024 - 08:00 GMT

U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable ...

Alvotech will manufacture its high-concentration interchangeable biosimilar to Humira® (adalimumab) for Quallent Pharmaceuticals The strategic agreement is in alignment with Alvotech’s U.S. commercialization agreement with Teva Pharmaceuticals The high- …

Distribution channels: Companies, Technology ...

Published on April 25, 2024 - 13:00 GMT

Project Focus by Wim Tellier 250 fishermen create an amazing artwork in Madagascar

100 custom Iris coloured sails in one of the most beautiful lagoons of the world located in Madagascar. MALLE, BELGIUM, April 25, 2024 /⁨EINPresswire.com⁩/ -- Project Focus by Wim Tellier 250 fishermen work together to display 100 custom sails with their …

Distribution channels: Culture, Society & Lifestyle, Media, Advertising & PR ...

Published on April 25, 2024 - 10:46 GMT

EIN Presswire to Exhibit at Small Business Expo in New York City During National Small Business Week

Small businesses will learn the benefits of press release distribution WASHINGTON, D.C., USA, April 25, 2024 /⁨EINPresswire.com⁩/ -- EIN Presswire will be an exhibitor at Small Business Expo on May 2, 2024 at Javits Convention Center Hall 1E in New York …

Distribution channels: Agriculture, Farming & Forestry Industry, Amusement, Gaming & Casino ...

Published on April 24, 2024 - 14:56 GMT

mtDNA copy number contributes to growth diversity in allopolyploid fish

USA, April 24, 2024 /⁨EINPresswire.com⁩/ -- Researchers investigated the influence of ploidy level on mitochondrial DNA (mtDNA) copy number and gene expression in fish. They compared mtDNA copy numbers in liver and muscle of red crucian carp, common carp, …

Distribution channels: Science ...

Published on April 24, 2024 - 08:00 GMT

Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)

The confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid arthritis Alvotech is the first company to publicly …

Distribution channels:

Published on April 19, 2024 - 10:10 GMT

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (...

Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to the U.S. market the newly FDA approved high-concentration interchangeable biosimilar to Humira® The agreement broadens patient access and further …

Distribution channels: Companies, Technology ...

Published on April 16, 2024 - 21:30 GMT

Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)

SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva SELARSDI is expected to be marketed in the U.S. on or after February 21, 2025, following a …

Distribution channels: Technology ...

Published on April 3, 2024 - 11:41 GMT

Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024

REYKJAVIK, Iceland, April 03, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will host an audio call with a …

Distribution channels:

Iceland Press Releases Distributed by EIN Presswire